CLSI Blog Articles

Read the latest articles about CLSI and laboratory standards in the official CLSI Blog. Browse our most recent blog articles below.

Public Health Laboratory Appreciation Month: A Conversation With CLSI President Victor Waddell, PhD, MS

We’re celebrating Public Health Laboratory Awareness this September. To find out more about why public health laboratories are so important to all our lives, we spoke with Victor Waddell, PhD, MS, CLSI’s Board President, and Bureau Chief of the Arizona State Public Health Laboratory.

September is Newborn Screening Awareness Month

In 1963, as a result of a discovery by Dr. Robert Guthrie, newborns could finally be screened and receive treatment for a disease before symptoms appeared. Dr. Guthrie and his colleague published a paper outlining their discovery.

Member Case Study: Expanding CLSI Access With Health System Membership

We were pleased to welcome representatives from CLSI Health System Members Geisinger and HealthPartners during CLSI’s latest member webinar, Expanding CLSI Access With Health System Membership. Our guest speakers discussed how CLSI Health System Membership has benefited their organizations.

25 Years of Standards Excellence: An Interview with Jen Adams, CLSI Vice President, Standards and Quality

Our Vice President of Standards and Quality, Jen Adams, recently celebrated her 25th anniversary with CLSI. Jen’s unique experience in the world of standards, particularly medical laboratory standards, has made her an invaluable asset to CLSI throughout the years. We celebrate Jen’s contributions to CLSI and the global standards community.

CLSI Expert Speaker Highlights from ADLM (AACC) 2023

Clinical and Laboratory Standards Institute (CLSI) was excited to participate in the Association for Diagnostics & Laboratory Medicine (ADLM) 2023 Annual Meeting and Expo (formerly AACC). A celebration of ADLM’s 75th anniversary, the conference brought together over 70K participants from clinical chemistry, diagnostics, lab management, and other laboratory science areas.

AST News Update June 2023: Aminoglycoside Case Study

A 45-year-old patient with acute myeloid leukemia (AML) received induction chemotherapy 2 weeks ago and currently has an absolute neutrophil count of <100 cells/μL. The patient had been on levofloxacin prophylaxis for his neutropenia, but developed a fever a week ago, at which point meropenem was started. All cultures and imaging were negative.

AST News Update June 2023: New! CLSI M100-Ed33: Updated Aminoglycoside Breakpoints for Enterobacterales and Pseudomonas aeruginosa

Major changes to the aminoglycoside (gentamicin, tobramycin, and amikacin) breakpoints were published in CLSI M100-Ed33.

AST News Update June 2023: New CLSI Intrinsic Resistance Guidance for Fungi

A 60-year-old female with a history of colon cancer presented to the Emergency Department with acute onset of abdominal pain. She had a recent proctocolectomy (removal of rectum and part of colon). Her temperature was normal, blood pressure was 136/70, and heart rate was 149 beats per minute.

AST News Update June 2023: The Latest on Testing Cefiderocol

In the July 2020 issue of this News Update, cefiderocol (trade name Fetroja®, manufactured by Shionogi) was discussed to include its projected use, requirements for testing, and more. Since that time, several new developments have occurred for cefiderocol testing.

What Does the End of the Federal COVID-19 Public Health Emergency Mean for Medical Labs & Device Manufacturers?

The end of the federal COVID-19 Public Health Emergency (PHE) on May 11, 2023 means that medical laboratories and device manufacturers will need to adjust their reporting requirements. During the PHE, the Department of Health and Human Services (HHS) had the authority to require lab tests for COVID-19 be reported to the Centers for Disease Control (CDC). This reporting requirement is no longer in effect.